AWC
VRTX icon

Abundance Wealth Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History

Abundance Wealth Counselors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408K Buy
913
+250
+38% +$117K 0.06% 157
2025
Q4 		$301K Buy
663
+1
+0.2% +$431 0.05% 139
2025
Q3 		$259K Sell
662
-84
-11% -$35.1K 0.04% 143
2025
Q2 		$332K Buy
746
+100
+15% +$46.1K 0.06% 132
2025
Q1 		$313K Buy
+646
New +$301K 0.07% 130
2024
Q3 		– Sell
-429
Closed -$201K – 139
2024
Q2 		$201K Buy
+429
New +$186K 0.09% 70

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Abundance Wealth Counselors's VRTX Position: Q1 2026 in Review

Abundance Wealth Counselors increased its Vertex Pharmaceuticals (VRTX) stake by 38% in Q1 2026, buying an estimated $117K and bringing the position to 913 shares worth $408K. The position accounts for 0.06% of the portfolio, ranked #157.

Abundance Wealth Counselors first reported a position in VRTX in Q2 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Abundance Wealth Counselors held 913 shares of Vertex Pharmaceuticals worth $408K as of Q1 2026.
  • Abundance Wealth Counselors bought 250 Vertex Pharmaceuticals shares in Q1 2026, an estimated $117K.
  • Vertex Pharmaceuticals made up 0.06% of Abundance Wealth Counselors's portfolio in Q1 2026, its #157 holding.
  • Abundance Wealth Counselors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Abundance Wealth Counselors's 13F filing for Q1 2026, filed 23 Apr 2026.